Delivery Order SPE2DR25D3501-SPE2DR26FL8NU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The Defense Logistics Agency awarded a $5,616.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack UDS (unit dose packs) with a completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a specialized nasal spray medication indicated for treatment-resistant depression, representing a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,904.65 on May 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems (UDS). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Spravato is an FDA-approved nasal spray medication primarily used for treatment-resistant depression, making this a specialized...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack units of use, valued at $11,134.62 on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $35,510.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems on October 28, 2025, with completion expected by October 29, 2025. This non-set-aside competitively awarded contract represents a pharmaceutical supply delivery under the Defense Health Supply Chain, supporting federal medical procurement needs across military and veteran healthcare systems. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.06 to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems (UDS) on October 30, 2025, with completion targeted for October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Spravato 84 mg dose pack unit dose systems, with a ceiling value of $11,110.02. This firm fixed price delivery order is scheduled for completion by October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition without a set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack units of service (UDS) under a firm fixed-price contract with a ceiling value of $9,243.49. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded delivery order contains no set-aside designation and represents a...
- The Defense Logistics Agency awarded a $1,417.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561835820 SPRAVATO 56 MG DOSE PACK UDS. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will deliver the pharmaceutical products to the same location by August 17, 2023. This delivery order was issued against an existing DLA contract vehicle to supply SPRAVATO, an esketamine nasal spray used to treat...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,860.83 firm-fixed-price delivery order is for SPRAVATO 84 MG DOSE PACK UDS, a medication, with an ultimate completion date of July 11, 2025. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL8NUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,852.37 to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack unit dose systems (UDS), with completion scheduled for November 14, 2025. This firm fixed price delivery order, awarded on November 13, 2025, represents a non-set-aside competitive award and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. SPRAVATO is a nasal spray formulation of esketamine indicated for treatment-resistant depression, reflecting the Defense Logistics Agency's procurement of specialized pharmaceutical products for military healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad portfolio of pharmaceutical products and medical supplies—including specialty medications, generic and brand-name drugs, vaccines, and related medical commodities—to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's consistent award of competitively-bid delivery orders across multiple therapeutic domains demonstrates its established capability as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 11/13/25 |